Where would you like to sign in?

INVO Bioscience Announces the First INVO Birth in South America

BEVERLY, MA--(Marketwire - February 4, 2010) - INVO Bioscience, Inc. (OTCBB: IVOB), a medical
device company focused on treatment options for patients diagnosed with
infertility, announces the birth of the first INVO baby in Venezuela. The
baby boy was born on January 31, 2010 to a 46-year-old woman who had been
treated at the CEVALFES Center for Fertility in Valencia. The mother Yolima
Nelo said, "I am very happy and send many kisses to Claude (Dr. Ranoux) for
this great result." The mother and new baby boy Rodolfo Francisco are
doing well. Dr. Antonia Sonoja, the physician who performed this INVO
procedure, was one of the key note speakers at the Salvador Society of
Endoscopy and Reproduction Symposium on January 30th where INVO was
presented to over 100 doctors from Central and South America.

About INVO Bioscience

INVO Bioscience (IVOB) is a medical device company, headquartered in
Beverly, Massachusetts, focused on creating simplified, lower cost
treatment options for patients diagnosed with infertility. The company's
main product, the INVOcell, is a novel medical device used in an
infertility treatment that enables egg fertilization and early embryo
development in the woman's vaginal cavity. The woman's body acts as a
natural incubator making it a much more personal experience. The company
was founded by Claude Ranoux, MD, a noted expert in the field of
reproductive health, infertility and embryology. For more information,
please visit www.invobioscience.com.

This release includes forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. All statements regarding
our expected future financial position, results of operations, cash flows,
financing plans, business strategies, products and services, competitive
positions, growth opportunities, plans and objectives of management for
future operations, as well as statements that include words such as
"anticipate," "if," "believe," "plan," "estimate," "expect," "intend,"
"may," "could," "should," "will," and other similar expressions are
forward-looking statements. All forward-looking statements involve risks,
uncertainties and contingencies, many of which are beyond our control,
which may cause actual results, performance, or achievements to differ
materially from anticipated results, performance, or achievements. Factors
that may cause actual results to differ materially from those in the
forward-looking statements include those set forth in our filings at
www.sec.gov. We are under no obligation to (and expressly disclaim any such
obligation to) update or alter our forward-looking statements, whether as a
result of new information, future events or otherwise.